NovaBridge Biosciences Income Statement (2018-2025) | NBP

Income Statement Dec2018 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.08B0.01B0.08B0.08B0.08B0.09B0.10B
Revenue & cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B
Operating items
Research & Development (Quarter)
-0.04B0.09B-0.10B0.33B-0.14B-0.00B-0.01B0.03B-0.01B-0.01B-0.00B0.01B-0.00B-0.00B0.01B0.06B
Selling, General & Administrative (Quarter)
-0.00B0.18B-0.04B-0.01B-0.01B-0.01B0.05B-0.00B-0.01B-0.01B0.05B-0.00B-0.00B-0.01B0.05B
Other Operating Expenses (Quarter)
-0.00B-0.01B0.00B
Operating Expenses (Quarter)
-0.05B0.26B-0.15B0.32B-0.01B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Operating Income (Quarter)
-0.04B-0.05B88.52B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
EBIT (Quarter)
-0.04B-0.05B88.52B0.16B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Non-operating items
Non Operating Investment Income (Quarter)
0.12B
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B0.06B-0.00B-0.02B0.00B0.00B-0.00B0.01B-0.01B0.00B0.00B-0.00B0.00B-0.00B
Net income details
EBT (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Tax Provisions (Quarter)
-0.00B-0.01B
Profit After Tax (Quarter)
-0.03B-0.05B-0.08B0.16B0.06B-0.05B-0.07B-0.02B0.03B0.02B-0.01B-0.00B-0.01B-0.01B-0.07B
Income from Non-Controlling Interests (Quarter)
-0.01B0.01B-0.05B
Income from Continuing Operations (Quarter)
-0.04B-0.05B-0.08B0.16B-0.03B-0.01B-0.04B-0.01B-0.01B-0.02B-0.00B-0.00B-0.01B-0.01B-0.07B
Income from Discontinued Operations (Quarter)
-0.18-0.130.18
Consolidated Net Income (Quarter)
-0.04B-0.05B-0.08B0.16B0.03B0.03B-0.01B420.000.01B-0.00B-0.01B-0.01B-0.07B
Income towards Parent Company (Quarter)
-0.04B-0.05B-0.08B0.16B330.00-90.00-0.01B-90.00250.000.01B-0.00B-0.01B-0.01B-0.07B
Net Income towards Common Stockholders (Quarter)
-0.04B-0.05B-0.08B0.16B320.000.03B-0.01B130.00-0.02B0.01B-0.00B-0.01B-0.01B-0.07B
Additional items
EPS (Basic) (Quarter)
-4.89-7.34-0.651.170.000.17-0.040.00-0.110.07-0.02-0.03-0.03-0.33
EPS (Diluted) (Quarter)
-4.89-7.34-0.651.000.000.17-0.040.00-0.110.07-0.02-0.03-0.03-0.33
Shares Outstanding (Quarter)
0.01B0.01B0.12B0.13B0.13B0.17B0.17B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.21B0.22B
Shares Outstanding (Diluted) (Quarter)
0.01B0.01B0.12B0.13B0.16B0.17B0.17B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.19B0.21B0.22B
EBITDA (Quarter)
-0.04B-0.05B88.52B0.16B-0.01B-0.01B-0.04B-0.01B-0.02B-0.01B-0.01B-0.01B-0.01B-0.01B-0.07B
Interest Expenses (Quarter)
0.00B-0.00B0.18B0.00B0.08B0.01B0.14B0.17B0.00B0.00B0.00B0.02B0.00B
Tax Rate (Quarter)
-1.1675.62